The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...

Improving accessibility, affordability, and tailoring treatment and diagnostics to women's needs are some of the crucial measures to closing the health gap for the fairer sex by 2030, said experts at ...

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...

SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.

An editorial published in the New England Journal of Medicine 1 referred to the Photovoltaic Retina Implant Microarray (PRIMA) Implant (Science Corporation) as “the first treatment to restore vision” ...

For first-degree relatives of patients with Crohn disease, increased antibody response is associated with subsequent risk for CD.

Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, ...

Researchers at Nuclera completed the first Asian installations of its eProtein Discovery System at National Taiwan University ...